Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Buy
55
LFCR Quote, Financials, Valuation and Earnings
Last price:
$8.75
Seasonality move
:
0.47%
Day range:
$8.40 - $8.85
52-week range:
$4.76 - $8.85
Dividend yield:
0%
P/E ratio:
133.20x
P/S ratio:
2.38x
P/B ratio:
192.11x
Volume:
106.5K
Avg. volume:
155.7K
1-year change:
39.56%
Market cap:
$330.5M
Revenue:
$128.9M
EPS (TTM):
-$1.07
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 | |
|---|---|---|---|---|---|---|
| Revenue | $171.5M | $111.3M | $103.3M | $128.3M | $128.9M | |
| Revenue Growth (YoY) | -70.94% | -35.14% | -7.19% | 24.2% | 0.47% | |
| Cost of Revenues | $121.1M | $72.2M | $75.3M | $86.4M | $88.6M | |
| Gross Profit | $50.5M | $39.1M | $28M | $41.9M | $40.3M | |
| Gross Profit Margin | 29.42% | 35.11% | 27.1% | 32.63% | 31.27% | |
| R&D Expenses | $7.4M | $7.8M | $8.7M | $8.6M | $8.3M | |
| Selling, General & Admin | $37.7M | $34.7M | $39M | $40.5M | $44M | |
| Other Inc / (Exp) | -$25.4M | -$1.8M | -$26.6M | $34.8M | -$4.8M | |
| Operating Expenses | $45.1M | $42.5M | $47.7M | $49M | $52.3M | |
| Operating Income | $5.4M | -$3.4M | -$19.7M | -$7.2M | -$12M | |
| Net Interest Expenses | $10.4M | $15.6M | $17.6M | $18.1M | $21.8M | |
| EBT. Incl. Unusual Items | -$11.5M | -$20.7M | -$63.9M | $9.5M | -$38.7M | |
| Earnings of Discontinued Ops. | -$23.1M | -$101.2M | -$35.3M | $2.7M | -- | |
| Income Tax Expense | -$1.9M | -$5.2M | $308K | $183K | $43K | |
| Net Income to Company | -$32.7M | -$116.7M | -$99.6M | $12M | -$38.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.6M | -$15.5M | -$64.2M | $9.3M | -$38.7M | |
| Basic EPS (Cont. Ops) | -$1.12 | -$3.97 | -$3.32 | $0.39 | -$1.27 | |
| Diluted EPS (Cont. Ops) | -$1.12 | -$3.97 | -$3.32 | $0.33 | -$1.27 | |
| Weighted Average Basic Share | $29.3M | $29.5M | $30M | $30.5M | $34.8M | |
| Weighted Average Diluted Share | $29.3M | $29.5M | $30M | $36.7M | $34.8M | |
| EBITDA | $14M | $3.7M | -$9.4M | $812K | -$4M | |
| EBIT | $5.4M | -$3.4M | -$19.7M | -$7.2M | -$12M | |
| Revenue (Reported) | $171.5M | $111.3M | $103.3M | $128.3M | $128.9M | |
| Operating Income (Reported) | $5.4M | -$3.4M | -$19.7M | -$7.2M | -$12M | |
| Operating Income (Adjusted) | $5.4M | -$3.4M | -$19.7M | -$7.2M | -$12M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $31.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | 25.92% | |
| Cost of Revenues | -- | -- | -- | -- | $23.3M | |
| Gross Profit | -- | -- | -- | -- | $7.8M | |
| Gross Profit Margin | -- | -- | -- | -- | 25.04% | |
| R&D Expenses | -- | -- | -- | -- | $2M | |
| Selling, General & Admin | -- | -- | -- | -- | $8.9M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | $10.9M | |
| Operating Income | -- | -- | -- | -- | -$3.1M | |
| Net Interest Expenses | -- | -- | -- | -- | $6.4M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -$9.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $333K | |
| Net Income to Company | -- | -- | -- | -- | -$10M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$10M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.29 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.29 | |
| Weighted Average Basic Share | -- | -- | -- | -- | $37.4M | |
| Weighted Average Diluted Share | -- | -- | -- | -- | $37.4M | |
| EBITDA | -- | -- | -- | -- | -$1.1M | |
| EBIT | -- | -- | -- | -- | -$3.1M | |
| Revenue (Reported) | -- | -- | -- | -- | $31.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -$3.1M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -$3.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $135.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | $92.6M | |
| Gross Profit | -- | -- | -- | -- | $42.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | $8M | |
| Selling, General & Admin | -- | -- | -- | -- | $39.1M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | $46.7M | |
| Operating Income | -- | -- | -- | -- | -$4M | |
| Net Interest Expenses | -- | -- | -- | -- | $22.9M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -$32.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $401K | |
| Net Income to Company | -- | -- | -- | -- | -$32.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$32.5M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$1.07 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$1.07 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | $4M | |
| EBIT | -- | -- | -- | -- | -$4M | |
| Revenue (Reported) | -- | -- | -- | -- | $135.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -$4M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -$4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $41.6M | $23.7M | $24.5M | $24.7M | $31.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $31.2M | $17.7M | $21.8M | $19.3M | $23.3M | |
| Gross Profit | $10.4M | $6M | $2.7M | $5.4M | $7.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.9M | $2.2M | $2.1M | $2.2M | $2M | |
| Selling, General & Admin | $9.5M | $8.1M | $9.2M | $14.8M | $8.9M | |
| Other Inc / (Exp) | -$1.7M | $863K | $40K | $214K | -- | |
| Operating Expenses | $11.3M | $10.3M | $11.4M | $17M | $10.9M | |
| Operating Income | -$908K | -$4.3M | -$8.6M | -$11.6M | -$3.1M | |
| Net Interest Expenses | $6.7M | $3.2M | $3.9M | $5.4M | $6.4M | |
| EBT. Incl. Unusual Items | -$9.3M | -$6.7M | -$12.5M | -$16.3M | -$9.7M | |
| Earnings of Discontinued Ops. | -$1.8M | -$4.3M | $1.9M | -- | -- | |
| Income Tax Expense | -$1.7M | $4K | $88K | -$25K | $333K | |
| Net Income to Company | -$9.5M | -$11M | -$10.8M | -$16.2M | -$10M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.6M | -$6.7M | -$12.6M | -$16.2M | -$10M | |
| Basic EPS (Cont. Ops) | -$0.32 | -$0.37 | -$0.35 | -$0.53 | -$0.29 | |
| Diluted EPS (Cont. Ops) | -$0.32 | -$0.37 | -$0.35 | -$0.53 | -$0.29 | |
| Weighted Average Basic Share | $29.4M | $29.6M | $30.4M | $30.9M | $37.4M | |
| Weighted Average Diluted Share | $29.4M | $29.6M | $30.4M | $30.9M | $37.4M | |
| EBITDA | $4.1M | $19K | -$6.5M | -$9.6M | -$1.1M | |
| EBIT | -$908K | -$4.3M | -$8.6M | -$11.6M | -$3.1M | |
| Revenue (Reported) | $41.6M | $23.7M | $24.5M | $24.7M | $31.1M | |
| Operating Income (Reported) | -$908K | -$4.3M | -$8.6M | -$11.6M | -$3.1M | |
| Operating Income (Adjusted) | -$908K | -$4.3M | -$8.6M | -$11.6M | -$3.1M | |
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.2M | $991K | $19.1M | $8.5M | $8.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $41.4M | $38.3M | $29M | $31.2M | $43.7M | |
| Inventory | $63.1M | $36M | $40.8M | $40M | $32.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5M | $2.1M | $4.9M | $1.4M | $1.5M | |
| Total Current Assets | $148.3M | $116.7M | $93.9M | $81M | $85.7M | |
| Property Plant And Equipment | $137.4M | $124.2M | $138.7M | $151M | $129M | |
| Long-Term Investments | -- | -- | -- | -- | $1.9M | |
| Goodwill | $33.9M | $13.9M | $13.9M | $13.9M | $13.9M | |
| Other Intangibles | $25.6M | $4.2M | $4.2M | $4.2M | $4.2M | |
| Other Long-Term Assets | $157.7M | $15.7M | $2.9M | $5.7M | $6.6M | |
| Total Assets | $533.3M | $285.2M | $265.6M | $273.7M | $239.3M | |
| Accounts Payable | $16.3M | $13M | $22.1M | $16.3M | $8.2M | |
| Accrued Expenses | $4M | $6.5M | $7.1M | $3.5M | $1.9M | |
| Current Portion Of Long-Term Debt | -- | $98.2M | $580K | $943K | $3.4M | |
| Current Portion Of Capital Lease Obligations | $1.6M | $4.4M | $1.3M | $4M | $387K | |
| Other Current Liabilities | $42.6M | $4.7M | -- | $2.4M | $2.2M | |
| Total Current Liabilities | $101.9M | $176.6M | $39.3M | $38.9M | $30.2M | |
| Long-Term Debt | $185.3M | $7.7M | $110.8M | $125.5M | $128.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $330.5M | $197.4M | $230.5M | $219.8M | $191.9M | |
| Common Stock | $29K | $30K | $30K | $30K | $37K | |
| Other Common Equity Adj | -$1.4M | -$586K | -- | -- | -- | |
| Common Equity | $202.8M | $87.8M | -$4.2M | $11.3M | $1.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $202.8M | $87.8M | $35.1M | $53.9M | $47.4M | |
| Total Liabilities and Equity | $533.3M | $285.2M | $265.6M | $273.7M | $239.3M | |
| Cash and Short Terms | $1.2M | $991K | $19.1M | $8.5M | $8.3M | |
| Total Debt | $185.4M | $105.8M | $111.5M | $126.4M | $131.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $18.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $29.1M | |
| Inventory | -- | -- | -- | -- | $33.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | -- | $83.9M | |
| Property Plant And Equipment | -- | -- | -- | -- | $128.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | $235.2M | |
| Accounts Payable | -- | -- | -- | -- | $10.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $30M | |
| Long-Term Debt | -- | -- | -- | -- | $136.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $198.4M | |
| Common Stock | -- | -- | -- | -- | $37K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $36.8M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $235.2M | |
| Cash and Short Terms | -- | -- | -- | -- | $18.9M | |
| Total Debt | -- | -- | -- | -- | $137.3M | |
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$32.7M | -$116.7M | -$99.6M | $12M | -$38.7M | |
| Depreciation & Amoritzation | $19.9M | $18.1M | $13.3M | $8.9M | $8M | |
| Stock-Based Compensation | $3.4M | $2.6M | $3.6M | $6.2M | $10.2M | |
| Change in Accounts Receivable | $5.8M | -$6.1M | $10.8M | -$2.4M | -$2.3M | |
| Change in Inventories | -$3.4M | -$2.2M | -$14.8M | $862K | $7.7M | |
| Cash From Operations | $15M | -$22.6M | -$17.4M | -$217K | -$206K | |
| Capital Expenditures | $23.8M | $29.9M | $21.5M | $17.9M | $13.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$10.9M | $80M | -$4.8M | -$17.9M | -$6.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $270M | $75.1M | $181.5M | $149.6M | $131M | |
| Long-Term Debt Repaid | -$262.5M | -$130.5M | -$178.3M | -$147.4M | -$146.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$10.9M | -$1.6M | -$6.3M | $4.8M | -$435K | |
| Cash From Financing | -$3.4M | -$57M | $39.7M | $7.5M | $6.4M | |
| Beginning Cash (CF) | $1.2M | $991K | $19.1M | $8.5M | $8.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $742K | $348K | $17.4M | -$10.6M | -$197K | |
| Ending Cash (CF) | $1.9M | $1.3M | $36.5M | -$2.2M | $8.1M | |
| Levered Free Cash Flow | -$8.8M | -$52.5M | -$38.9M | -$18.1M | -$13.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -$10M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $2M | |
| Stock-Based Compensation | -- | -- | -- | -- | $2.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | $65K | |
| Change in Inventories | -- | -- | -- | -- | $2M | |
| Cash From Operations | -- | -- | -- | -- | $1.8M | |
| Capital Expenditures | -- | -- | -- | -- | $1.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -$1.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -$1.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $18.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$1.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | $17.5M | |
| Levered Free Cash Flow | -- | -- | -- | -- | $25K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -$32.5M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $8M | |
| Stock-Based Compensation | -- | -- | -- | -- | $10.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$8.2M | |
| Change in Inventories | -- | -- | -- | -- | $11.3M | |
| Cash From Operations | -- | -- | -- | -- | $2.2M | |
| Capital Expenditures | -- | -- | -- | -- | $11.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -$4.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $3.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | $1.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -$9.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.5M | -$11M | -$10.8M | -$16.2M | -$10M | |
| Depreciation & Amoritzation | $5.1M | $4.4M | $2.2M | $2M | $2M | |
| Stock-Based Compensation | $620K | $785K | $1.5M | $2.4M | $2.4M | |
| Change in Accounts Receivable | $8M | $7.2M | $2.4M | $6M | $65K | |
| Change in Inventories | $248K | $2.6M | -$849K | -$1.7M | $2M | |
| Cash From Operations | $699K | -$1.1M | -$8.3M | -$613K | $1.8M | |
| Capital Expenditures | $7.9M | $3.4M | $5.1M | $3.4M | $1.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $38.3M | -$226K | -$5.1M | -$3.4M | -$1.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $8M | $4M | $2.3M | $1.9M | -- | |
| Long-Term Debt Repaid | -$46.4M | -$27K | -$26K | -$233K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$560K | -$67K | -$45K | -$589K | -- | |
| Cash From Financing | -$38.8M | $3.9M | $2.9M | $1.1M | -$1.4M | |
| Beginning Cash (CF) | $1.4M | $4.2M | $8.6M | $5.5M | $18.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $152K | $2.6M | -$10.4M | -$2.9M | -$1.4M | |
| Ending Cash (CF) | $1.6M | $6.8M | -$1.8M | $2.6M | $17.5M | |
| Levered Free Cash Flow | -$7.2M | -$4.5M | -$13.4M | -$4M | $25K | |
Get LFCR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LFCR
Sector
P/E ratio
133.20x
23.82x
PEG ratio
-0.05x
-0.01x
P/B ratio
192.11x
1.83x
Price / LTM sales
2.38x
1.56x
Growth Metrics
LFCR
Sector
Revenue growth
25.92%
4.18%
Earnings growth
44.53%
9.66%
Revenue (5-year growth)
-26.24%
6.28%
Earnings forecast
-$0.18
-$0.18
Profitability
LFCR
Sector
Profitability FY 2025
$40.3M
$3.1M
Return on invested capital
-18.06%
-32.89%
Return on assets
-13.37%
-29.56%
Return on equity
-70.33%
-38.66%
Earnings Date
Last Earnings Date
Apr
3
Next Earnings Date
Feb
2
Estimated Next Earnings Date
Jul
3
Balance Sheet
LFCR
Sector
Total cash
$18.9M
$25.2M
Short term investments
--
$25.1M
Total assets
$239.3M
$73M
Long term debt
$137.3M
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
52
CVLT alert for Jan 27
Commvault Systems, Inc. [CVLT] is down 29.45% over the past day.
Sell
47
AGYS alert for Jan 27
Agilysys, Inc. [AGYS] is down 20.3% over the past day.
Buy
71
GLSI alert for Jan 27
Greenwich LifeSciences, Inc. [GLSI] is up 1.8% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
